[1]
|
Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis
Immunotherapy,
2017
DOI:10.2217/imt-2016-0079
|
|
|
[2]
|
Double-Blind, Placebo-Controlled, 1:1 Randomized Phase III Clinical Trial Of Immunoxel Honey Lozenges as an Adjunct Immunotherapy in 269 Patients with Pulmonary Tuberculosis
Immunotherapy,
2017
DOI:10.2217/imt-2016-0079
|
|
|
[3]
|
Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy
International Journal of Mycobacteriology,
2016
DOI:10.1016/j.ijmyco.2016.06.012
|
|
|
[4]
|
Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7)
Immunotherapy,
2013
DOI:10.2217/imt.13.110
|
|
|
[5]
|
Randomized, placebo-controlled phase II trial of heat-killedMycobacterium vaccae(Longcom batch) formulated as an oral pill (V7)
Human Vaccines & Immunotherapeutics,
2013
DOI:10.4161/hv.25280
|
|
|
[6]
|
Randomized, Placebo-Controlled Phase II Trial of Heat-Killed
Mycobacterium Vaccae
(Immodulon Batch) Formulated as an Oral Pill (V7)
Immunotherapy,
2013
DOI:10.2217/imt.13.110
|
|
|
[7]
|
Immune approaches in tuberculosis therapy: a brief overview
Expert Review of Anti-infective Therapy,
2012
DOI:10.1586/eri.12.1
|
|
|
[8]
|
Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV
Immunotherapy,
2012
DOI:10.2217/imt.12.59
|
|
|
[9]
|
Adjunct Immune Therapy of First-Diagnosed TB, Relapsed TB, Treatment-Failed TB, Multidrug-Resistant TB and TB/HIV
Immunotherapy,
2012
DOI:10.2217/imt.12.59
|
|
|